1.
Kwatra SG, de Bruin-Weller M, Silverberg JI, Lio P, Deleuran M, Aydin H, et al. Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib. Acta Derm Venereol [Internet]. 2024 May 6 [cited 2024 Nov. 21];104:adv18452. Available from: https://medicaljournalssweden.se/actadv/article/view/18452